In the last trading session, 5.73 million shares of the ORIC Pharmaceuticals Inc (NASDAQ:ORIC) were traded, and its beta was 1.17. Most recently the company’s share price was $11.23, and it changed around -$1.02 or -8.33% from the last close, which brings the market valuation of the company to $792.47M. ORIC currently trades at a discount to its 52-week high of $16.65, offering almost -48.26% off that amount. The share price’s 52-week low was $6.33, which indicates that the current value has risen by an impressive 43.63% since then. We note from ORIC Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 1.12 million shares, with the 3-month average coming to 565.98K.
ORIC Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.08. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ORIC as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight. ORIC Pharmaceuticals Inc is expected to report earnings per share of -0.51 for the current quarter.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
Instantly ORIC has showed a red trend with a performance of -8.33% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 14.67 on recent trading dayincreased the stock’s daily price by 23.45%. The company’s shares are currently up 39.16% year-to-date, but still up 10.64% over the last five days. On the other hand, ORIC Pharmaceuticals Inc (NASDAQ:ORIC) is 32.12% up in the 30-day period. We can see from the shorts that 10.52 million shares have been sold at a short interest cover period of 17.67 day(s).
The consensus price target as assigned by Wall Street analysts is $20, which translates to bulls needing to increase their stock price by 43.85% from its current value. Analyst projections state that ORIC is forecast to be at a low of $20 and a high of $20.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -22.33%. ORIC Pharmaceuticals Inc earnings are expected to increase by 5.14% in 2025, but the outlook is negative -2.58% per year for the next five years.
ORIC Dividends
ORIC Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in March.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.50% of ORIC Pharmaceuticals Inc shares, and 102.32% of them are in the hands of institutional investors. The stock currently has a share float of 113.06%. ORIC Pharmaceuticals Inc stock is held by 185.0 institutions, with NEXTECH INVEST LTD. being the largest institutional investor. By 2024-06-30, it held 7.8482% of the shares, which is about 5.29 million shares worth $37.37 million.
FMR LLC, with 7.3057% or 4.92 million shares worth $34.79 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
